Sign in

CIK 0001082554 · Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
521984749
Phone
3016089292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$342,898,837
in 74 filings, $342.1M under 10b5-1 plans

Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Option exercise 10b5-1 +3,517 $146.03 $514K 11,659
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −160 $491.53 $79K 11,499
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −840 $492.81 $414K 10,659
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −561 $493.70 $277K 10,098
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −360 $495.02 $178K 9,738
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −520 $495.90 $258K 9,218
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −200 $496.97 $99K 9,018
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −395 $498.09 $197K 8,623
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −240 $499.31 $120K 8,383
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −241 $500.30 $121K 8,142
2025-12-15 EDGEMOND JAMES CFO AND TREASURER Option exercise · Stock Option 10b5-1 −3,517 0
2025-12-15 PATUSKY CHRISTOPHER Director Option exercise +1,000 $101.80 $102K 2,490
2025-12-15 PATUSKY CHRISTOPHER Director Sale −1,000 $495.95 $496K 1,490
2025-12-15 PATUSKY CHRISTOPHER Director Option exercise · Stock Option −1,000 3,910
2025-12-15 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 10b5-1 +4,000 $120.26 $481K 4,130
2025-12-15 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −500 $491.77 $246K 3,630
2025-12-15 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −3,500 $495.14 $1.7M 130
2025-12-15 ROTHBLATT MARTINE A Chairperson & CEO Option exercise · Stock Option 10b5-1 −4,000 14,000
2025-12-12 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 10b5-1 +4,000 $120.26 $481K 4,130
2025-12-12 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −1,100 $489.95 $539K 3,030

Page 169 of 171 · 3,408 trades